The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects

Summary

The study is a randomized, single-blind, placebo-controlled, multiple-dose escalation Phase I trials. 2 dose groups were designed, 12 subjects in each dose group.The drug was administered single dose and multiple doses.

Timeline

Start

2020-08-11

Primary completion

2020-11-08

Completion

2020-11-08

Drugs

Indications